Hydralazine Hydrochloride Tablet
Product Images NDC 70518-3852

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-3852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication called hydrALAZINE HCI. It is a tablet with a strength of 25 mg. The medication is packaged in a bottle containing 30 tablets. The NDC number for the medication is 70518-3852-00. The source NDC number is 50228-0183-10, indicating the manufacturer as ScieGen Pharmaceuticals, Inc. The medication should be stored at a temperature range of 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) [See USP]. The medication should be kept out of the reach of children. The lot number and expiration date are not provided in the text. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA.*
FDA Label Image

Chem Structure (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.